Pricing Log in Create free account

BioVie Inc. (BIVI) vs Tvardi Therapeutics, Inc. (TVRD)

BioVie Inc. and Tvardi Therapeutics, Inc. are both Biotechnology companies. Tvardi Therapeutics, Inc. is the larger, with a market value of $11.5M against $10.3M — 1.1× the size. Across the 10 metrics below, BioVie Inc. leads on 6 and Tvardi Therapeutics, Inc. on 4.

Valuation

Metric BIVI TVRD Biotechnology median
P/E n/m n/m 10.26
P/S n/m 1.05 9.18
P/B 0.85 0.95 2.05
Price to free cash flow n/m n/m 24.81
EV/EBITDA n/m n/m 0.65
EV/Sales n/m 6.83 8.98
Earnings yield (260.33%) (328.24%) (34.89%)
Free cash flow yield (216.99%) (353.24%) (24.52%)

Profitability

Metric BIVI TVRD Biotechnology median
Gross margin 0.00% 146.85% 65.16%
Operating margin 0.00% 0.00% 0.00%
Net margin 0.00% 0.00% 0.00%
Free cash flow margin 0.00% 0.00% 0.00%
Return on equity (151.06%) (126.19%) (50.12%)
Return on assets (123.51%) (85.08%) (45.60%)
Return on invested capital (1,095.01%) 0.00% 0.00%

Growth

Metric BIVI TVRD Biotechnology median
Revenue growth (TTM) — (55.30%) 6.26%
EPS growth (last fiscal year) 74.83% 71.45% 29.88%
Revenue growth, 5-year CAGR — (18.53%) 9.75%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric BIVI TVRD Biotechnology median
Debt to equity 0.00 0.00 0.00
Current ratio 3.59 1.87 4.89
Net debt to EBITDA 0.40 1.15 1.01

Dividend

Metric BIVI TVRD Biotechnology median
Dividend yield — — 0.41%
Payout ratio — — —

Size

Metric BIVI TVRD Biotechnology median
Market cap 10.32m 11.53m 172.11m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack